{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:00:05Z","timestamp":1792432805484,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10792-018-0955-6","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T12:40:56Z","timestamp":1529412056000},"page":"1355-1366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Novel hydrogel-based ocular drug delivery system for the treatment of conjunctivitis"],"prefix":"10.1007","volume":"39","author":[{"given":"S.","family":"Deepthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobin","family":"Jose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"955_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/187221109789105621","volume":"3","author":"MA Babizhayev","year":"2009","unstructured":"Babizhayev MA (2009) Current ocular drug delivery challenges for N-acetylcarnosine: novel patented routes and modes of delivery, design for enhancement of therapeutic activity and drug delivery relationship. Recent Patient Drug Deliv Formul 3:229\u2013265","journal-title":"Recent Patient Drug Deliv Formul"},{"key":"955_CR2","first-page":"579","volume":"161","author":"RW Snyder","year":"1994","unstructured":"Snyder RW, Glasser DB (1994) Antibiotic therapy for ocular infection. West J Med 161:579\u2013584","journal-title":"West J Med"},{"key":"955_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/jps.2600800113","volume":"80","author":"JC Keister","year":"1991","unstructured":"Keister JC, Cooper ER, Missel PJ, Lang JC, Hager DF (1991) Limits on optimizing ocular drug delivery. J Pharm Sci 80:50\u201353","journal-title":"J Pharm Sci"},{"key":"955_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4103\/0301-4738.71677","volume":"58","author":"V Singh","year":"2010","unstructured":"Singh V, Bushetti SS, Appala R, Shareef A, Imam SS, Singh M (2010) Stimuli sensitive hydrogels: a novel ophthalmic drug delivery system. Indian J Ophthalmol 58:477\u2013481","journal-title":"Indian J Ophthalmol"},{"key":"955_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S1461-5347(98)00087-X","volume":"1","author":"S Ding","year":"1998","unstructured":"Ding S (1998) Recent development in ophthalmic drug delivery. Pharm Sci Technol Today 1:328\u2013335","journal-title":"Pharm Sci Technol Today"},{"key":"955_CR6","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","volume":"26","author":"R Gaudana","year":"2009","unstructured":"Gaudana R, Jwala J, Boddu SH, Mitra AK (2009) Recent perspectives in ocular drug delivery. Pharm Res 26:1197\u20131216","journal-title":"Pharm Res"},{"key":"955_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1021\/js970090e","volume":"87","author":"SD Desai","year":"1998","unstructured":"Desai SD, Blanchard J (1998) In vitro evaluation of Poloxamer 407 based controlled release ocular delivery system for the pilocarpine. J Pharm Sci 87:226\u2013230","journal-title":"J Pharm Sci"},{"key":"955_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0939-6411(00)00090-4","volume":"50","author":"NA Peppas","year":"2000","unstructured":"Peppas NA, Bures P, Leobandung W, Ichikawa H (2000) Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm 50:27\u201346","journal-title":"Eur J Pharm Biopharm"},{"key":"955_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0168-3659(01)00279-6","volume":"73","author":"B Srividya","year":"2001","unstructured":"Srividya B, CardozaRM Amin PD (2001) Sustained ophthalmic delivery of the oflaxin from a pH triggered in situ gelling systems. J Control Rel 73:205\u2013211","journal-title":"J Control Rel"},{"key":"955_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/S0168-3659(00)00329-1","volume":"69","author":"HR Lin","year":"2000","unstructured":"Lin HR, Sung KC (2000) Carbopol\/pluronic phase change solution for the ophthalmic drug delivery. J Control Release 69:379\u2013388","journal-title":"J Control Release"},{"key":"955_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0169-409X(97)00121-X","volume":"31","author":"LE Bromberg","year":"1998","unstructured":"Bromberg LE, Ron ES (1998) Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev 31:197\u2013221","journal-title":"Adv Drug Deliv Rev"},{"key":"955_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1248\/yakushi.127.183","volume":"127","author":"C Wu","year":"2007","unstructured":"Wu C, Qi H, Chen W, Huang C, Su C, Li W et al (2007) Preparation and evaluation of a Carbopol\/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku Zasshi 127:183\u2013191","journal-title":"Yakugaku Zasshi"},{"key":"955_CR13","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpharm.2006.01.029","volume":"315","author":"Z Liu","year":"2006","unstructured":"Liu Z, Li J, Nie S, Liu H, Ding P, Pan W (2006) Study of an alginate\/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 315:12\u201317","journal-title":"Int J Pharm"},{"key":"955_CR14","first-page":"175","volume":"22","author":"S Abraham","year":"2009","unstructured":"Abraham S, Furtado S, Bharath S, Basavaraj BV, Deveswaran R, Madhavan V (2009) Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. Pak J Pharm Sci 22:175\u2013179","journal-title":"Pak J Pharm Sci"},{"key":"955_CR15","first-page":"19","volume":"39","author":"R Masteikova","year":"2003","unstructured":"Masteikova R, Chalupova Z (2003) Stimuli sensitive hydrogels in controlled and sustained drug delivery. Medicina (Kaunas) 39:19\u201324","journal-title":"Medicina (Kaunas)"},{"key":"955_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jconrel.2007.01.004","volume":"119","author":"T Coviello","year":"2009","unstructured":"Coviello T, Matricardi P, Marianecci C, Alhaique F (2009) Polysaccharide hydrogels for modified release formulations. J Control Release 119:5\u201324","journal-title":"J Control Release"},{"key":"955_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0168-3659(01)00279-6","volume":"73","author":"B Srividya","year":"2001","unstructured":"Srividya B, Cardoza RM, Amin PD (2001) Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release 73:205\u2013211","journal-title":"J Control Release"},{"key":"955_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0928-0987(97)00074-2","volume":"6","author":"J Carlfors","year":"1998","unstructured":"Carlfors J, Edsman K (1998) Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci 6:113\u2013119","journal-title":"Eur J Pharm Sci"},{"key":"955_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jconrel.2007.01.004","volume":"119","author":"T Coviello","year":"2009","unstructured":"Coviello T, Matricardi P, Marianecci C, Alhaique F (2009) Polysaccharide hydrogels for modified release formulations. J Control Release 119:5\u201324","journal-title":"J Control Release"},{"issue":"3","key":"955_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/jps.2600840315","volume":"84","author":"S Kumar","year":"1995","unstructured":"Kumar S, Himmelstein KJ (1995) Modification of in situ gelling behaviour of carbopol solution by hydroxyl propyl methyl cellulose. J Pharm Sci 84(3):344\u2013348","journal-title":"J Pharm Sci"},{"key":"955_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0378-5173(85)90230-3","volume":"26","author":"HW Hui","year":"1985","unstructured":"Hui HW, Robinson JR (1985) Ocular drug delivery of progesterone using of bioadhesion polymer. Int J Pharm 26:203\u2013213","journal-title":"Int J Pharm"},{"key":"955_CR22","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1016\/S0142-9612(03)00035-8","volume":"24","author":"GH Hsiue","year":"2003","unstructured":"Hsiue GH, Chang RW, Wang CH, Lee SH (2003) Development of in situ thermosensitive drug vehicles for glaucoma therapy. Biomaterials 24:2423\u20132430","journal-title":"Biomaterials"},{"key":"955_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/0278-6915(85)90030-4","volume":"23","author":"N Luepke","year":"1985","unstructured":"Luepke N (1985) Hen\u2019s egg chorioallantoic membrane test for irritation potential. Food Chem Toxicol 23:287\u2013291","journal-title":"Food Chem Toxicol"},{"key":"955_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0887-2333(98)00091-5","volume":"13","author":"W Steiling","year":"1999","unstructured":"Steiling W, Bracher M, Courtellemont P, de Silva O (1999) The HET-CAM, a useful in vitro assay for assessing the eye irritation properties of cosmetic formulations and ingredients. Toxicol In Vitro 13:375\u2013384","journal-title":"Toxicol In Vitro"},{"key":"955_CR25","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.yrtph.2011.02.003","volume":"59","author":"J Scheel","year":"2011","unstructured":"Scheel J, Kleber M, Kreutz J (2011) Eye irritation potential: usefulness of the HET-CAM under the globally harmonized system of classification and labeling of chemicals (GHS). Reg Toxicol Pharmacol 59:471\u2013492","journal-title":"Reg Toxicol Pharmacol"},{"key":"955_CR26","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.addr.2007.04.019","volume":"59","author":"A Vargas","year":"2007","unstructured":"Vargas A, Zeisser-Labou\u00e8be M, Lange N, Gurny R, Delie F (2007) The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Ver 59:1162\u20131176","journal-title":"Adv Drug Deliv Ver"},{"key":"955_CR27","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.tiv.2010.11.012","volume":"25","author":"C Bender","year":"2011","unstructured":"Bender C, Partecke L, Kindel E (2011) The modified HET-CAM as a model for the assessment of the inflammatory response to tissue tolerable plasma. Toxicol In Vitro 25:530\u2013537","journal-title":"Toxicol In Vitro"},{"key":"955_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00006982-200406000-00014","volume":"24","author":"T Leng","year":"2004","unstructured":"Leng T, Miller JM, Bilbao KV, Palanker DV, Huie P, Blumenkranz MS (2004) The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation. Retina 24:4","journal-title":"Retina"},{"key":"955_CR29","first-page":"2194","volume":"33","author":"FQ Liang","year":"1992","unstructured":"Liang FQ, Viola RS, del Cerro M, Aquavella JV (1992) Noncross-linked collagen discs and cross-linked collagen shields in the delivery of gentamicin to rabbits eyes. Invest Ophthalmol Vis Sci 33:2194\u20132198","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"955_CR30","first-page":"250","volume":"9","author":"SR Waltman","year":"1970","unstructured":"Waltman SR, Kaufman HE (1970) The use of soft contact lenses to increase ocular penetration of topical drugs. Investig Ophthalmol Vis Sci 9:250\u2013255","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"955_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/jop.1994.10.17","volume":"10","author":"HE Kaufman","year":"1994","unstructured":"Kaufman HE, Steinemann TL, Lehman E, Thompson HW, Varnell ED, Jacob-LaBarre JT, Gebhardt BM (1994) Collagen-based drug delivery and artificial tears. J Ocul Pharmacol 10:17\u201327","journal-title":"J Ocul Pharmacol"},{"key":"955_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0002-9394(71)90846-4","volume":"72","author":"JV Aquavella","year":"1971","unstructured":"Aquavella JV, Jackson GK, Guy LF (1971) Bionite hydropiiilic contact lenses used as cosmetic devices. Am J Ophthalmol 72:527\u2013531","journal-title":"Am J Ophthalmol"},{"key":"955_CR33","first-page":"1341","volume":"3","author":"JV Aquavella","year":"1971","unstructured":"Aquavella JV, Jackson GK, Guy LF (1971) Therapeutic effects of bionite lenses: mechanisms of action. Ann Ophthalmol 3:1341\u20131345","journal-title":"Ann Ophthalmol"},{"key":"955_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0002-9394(70)91287-0","volume":"69","author":"AR Gasset","year":"1970","unstructured":"Gasset AR, Kaufman HE (1970) Therapeutic uses of hydrophilic contact lenses. Am J Ophthalmol 69:252\u2013259","journal-title":"Am J Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-018-0955-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0955-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T07:02:40Z","timestamp":1567234960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-018-0955-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s10792-018-0955-6","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"16 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the institutional and\/or national research committee or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}